CureDuchenne Ventures 2020 Pitch Contest: SUBMISSION DEADLINE JULY 13

For over a decade, CureDuchenne Ventures has funded promising research that advances us toward a cure for Duchenne muscular dystrophy. For the first time, CureDuchenne is holding a competition to stimulate and support new, innovative ideas from a wide array of sources.

This competition is an opportunity for colleges, universities and biotech and pharma companies with outstanding scientists at all career stages to pitch their latest idea and potentially be rewarded with $25,000

About the Contest:

• Open to colleges, universities, biotech companies and pharma companies in the United States with researchers at all career stages
• Focusing on new Duchenne therapeutics or therapeutic targets, or technology platforms that can help overcome current limitations of Duchenne therapies in development
• Finalists will have opportunity to pitch their idea to a panel of esteemed judges from the drug development and venture capital communities
• Email us at Pitch@CureDuchenne.org if you have any questions

The Winning Details:

• 2 Winners each receiving no-strings attached award of $25,000 by check made out to the winning college, university, or company
• Access to a wide array of experts in Duchenne drug discovery
• Ongoing mentoring from CureDuchenne lead scientists Mike Kelly, PhD & Lianna Orlando, PhD
•  

For more details visit the CureDuchenne Ventures 2020 Pitch Contest Website.